Biosynthesis, Processing, and Secretion of the Islet Hormones: Insulin, Islet Amyloid Polypeptide (Amylin), Glucagon, Somatostatin, and Pancreatic Polypeptide

Endocrinology: Adult and Pediatric

Volumn 1-2, Issue , 2015, Pages 527-545.e6

  Steiner, Donald F ^a   Rhodes, Christopher J ^a   Philipson, Louis H ^a   Bell, Graeme I ^a   Chan, Shu Jin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84994460342     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-18907-1.00031-7     Document Type: Chapter

References (262)

1. Von Mering J., Minkowski O. Diabetes mellitus nach Pankreasexstirpation. Arch f exp Path u. Pharm 1889, 26:371-387.
2. Bliss M. The discovery of insulin 1982, University of Chicago Press, Chicago.
3. Scott E.L. On the influence of intravenous injections of an extract of the pancreas on experimental pancreatic diabetes. Am J Physiol 1912, 29:306-310.
4. Banting F.G., Best C.H., Collip J.B. Insulin patent. Chem Abstracts 1923, 17:3571.
5. Macleod J.J.R., Campbell W.R. Insulin: Its use in the treatment of diabetes. Medicine monographs 1925, vol VI. Williams & Wilkins, Baltimore, parts I and II.
6. Murnaghan J.H., Talalay P. John Jacob Abel and the crystallization of insulin. Perspect Biol Med 1967, 10:334-380.
7. Falkmer S., El-Salhy M., Titlbach M. Evolution of the neuroendocrine system in vertebrates: a review with particular reference to the phylogeny and postnatal maturation of the islet parenchyma. Evolution and tumour pathology of the neuroendocrine system 1984, 59-87. Elsevier, Amsterdam. S. Falkmer, R. Håkanson, F. Sundler (Eds.).
8. Humbel R.E., Bosshard H.R., Zahn H. Chemistry of insulin. Handbook of physiology, endocrinology I 1972, 111-132. Williams & Wilkins, Baltimore. D.F. Steiner, N. Freinkel (Eds.).
9. Sanger F. Chemistry of insulin. Science 1959, 129:1340-1344.
10. Rouillé Y., Duguay S.J., Lund K., et al. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 1995, 16:322-361.
11. Steiner D.F., Oyer P.E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci U S A 1967, 57:473-480.
12. Chance R.E., Ellis R.M., Bromer W.W. Porcine proinsulin: characterization and amino acid sequence. Science 1968, 161:165-167.
13. Steiner D.F., Clark J.L., Nolan D., et al. Proinsulin and the biosynthesis of insulin. Recent Prog Horm Res 1969, 25:207-282.
14. Oyer P.E., Cho S., Peterson J.D., et al. Studies on human proinsulin: isolation and amino acid sequence of the human pancreatic C-peptide. J Biol Chem 1971, 246:1375-1386.
15. Chan S.J., Keim P., Steiner D.F. Cell-free synthesis of rat preproinsulins: characterization and partial amino acid sequence determination. Proc Natl Acad Sci U S A 1976, 73:1964-1968.
16. Sanders S.L., Schekman R. Polypeptide translocation across the endoplasmic reticulum membrane. J Biol Chem 1992, 267:13791-13794.
17. Patzelt C., Labrecque A.D., Duguid J.R., et al. Detection and kinetic behavior of preproinsulin in pancreatic islets. Proc Natl Acad Sci U S A 1978, 75:1260-1264.
18. Frand A.R., Cuozzo J.W., Kaiser C.A. Pathways for protein disulphide bond formation. Trends Cell Biol 2000, 10:203-210.
19. Munro S., Pelham H.R.B. A C-terminal signal prevents secretion of luminal ER proteins. Cell 1987, 48:899-907.
20. Orci L., Perrelet A., Ravazzola, et al. Coatomer-rich endoplasmic reticulum. Proc Natl Acad Sci U S A 1994, 91:11924-11928.
21. Pagano A., Letourneur F., Garcia-Estefania D., et al. Sec24 proteins and sorting at the endoplasmic reticulum. J Biol Chem 1999, 274:7833-7840.
22. Steiner D.F., Kemmler W., Clark J.L., et al. The biosynthesis of insulin. Handbook of physiology, Endocrinology I 1972, 175-198. Williams & Wilkins, Baltimore. D.F. Steiner, N. Freinkel (Eds.).
23. Nishi M., Sanke T., Nagamatsu S., et al. Islet amyloid polypeptide: a new β cell secretory product related to islet amyloid deposits. J Biol Chem 1990, 265:4173-4176.
24. Steiner D.F., Clark J.L., Nolan C., et al. The biosynthesis of insulin and some speculation regarding the pathogenesis of human diabetes. The pathogenesis of diabetes mellitus 1970, 57-80. John Wiley & Sons, New York. E. Cerasi, R. Luft (Eds.).
25. Howell S.L. Role of ATP in the intracellular translocation of proinsulin and insulin in the rat pancreatic B cell. Nat New Biol 1972, 235:85-86.
26. Wattenberg B.W., Rothman J.E. Multiple cytosolic components promote intra-Golgi protein transport: resolution of a protein acting at a late state, prior to membrane fusion. J Biol Chem 1986, 261:2208-2213.
27. Chappell T.G., Welch W.F., Schlossman D.M., et al. Uncoating ATPase is a member of the 70 kDa family of stress proteins. Cell 1986, 45:3-13.
28. Munger B.L. A light and electron microscopic study of cellular differentiation in the pancreatic islets of the mouse. Am J Anat 1958, 103:275-311.
29. Mogelsvang S., Howell K.E. Global approaches to study Golgi function. Curr Opin Cell Biol 2006, 18:438-443.
30. Orci L., Ravazzola M., Amherdt M., et al. Direct identification of prohormone conversion site in insulin-secreting cells. Cell 1985, 42:671-681.
31. Steiner D.F. Evidence for a precursor in the biosynthesis of insulin. Trans N Y Acad Sci 1967, 30:60-68.
32. Nagamatsu S., Bolaffi J.L., Grodsky G.M. Direct effects of glucose on proinsulin synthesis and processing during desensitization. Endocrinology 1987, 120:1225-1231.
33. Orci L., Lambert A.E., Kanazawa Y., et al. Morphological and biochemical studies of B cells in fetal rat endocrine pancreas in organ culture: evidence for proinsulin biosynthesis. J Cell Biol 1971, 50:565-582.
34. Frank B.H., Veros A.J. Physical studies on proinsulin: association behavior and conformation in solution. Biochem Biophys Res Commun 1968, 32:155-160.
35. Rubenstein A.H., Mako M., Welbourne W.P., et al. Comparative immunology of bovine, porcine, and human proinsulin and C-peptides. Diabetes 1970, 19:546-553.
36. Weiss M.A., Frank B.H., Khait I., et al. NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry 1990, 29:8389-8401.
37. Gliemann J., Sorensen H.H. Assay of insulin-like activity by the isolated fat cell method: IV. The biological activity of proinsulin. Diabetologia 1970, 6:499-504.
38. Given B.D., Cohen R.M., Shoelson S.E., et al. Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest 1985, 76:1398-1405.
39. Frank B.H., Veros A.J. Interaction of zinc with proinsulin. Biochem Biophys Res Commun 1970, 38:284-289.
40. Steiner D.F. Cocrystallization of proinsulin and insulin. Nature 1973, 243:528-530.
41. Steiner D.F., Hallund O., Rubenstein A.H., et al. Isolation and properties of proinsulin, intermediate forms and other minor components from crystalline bovine insulin. Diabetes 1968, 17:725-736.
42. Blundell T., Wood S. The conformation, flexibility, and dynamics of polypeptide hormones. Annu Rev Biochem 1982, 51:123-154.
43. Low B.W., Fullerton W.W., Rosen L.S. Insulin/proinsulin, a new crystalline complex. Nature 1974, 248:339-340.
44. Nolan C., Margoliash E., Peterson J.D., et al. The structure of bovine proinsulin. J Biol Chem 1971, 246:2780-2795.
45. Kuzuya H., Chance R.E., Steiner D.F., et al. On the preparation and characterization of standard materials for natural human proinsulin and C-peptide. Diabetes 1978, 27:161-169.
46. Furuta M., Carroll R., Martin S., et al. Incomplete processing of proinsulin to insulin accompanied by elevation of des-31,32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem 1998, 273:3431-3437.
47. Chan S.J., Cao Q.P., Steiner D.F. Evolution of the insulin superfamily: cloning of a hybrid insulin/insulin-like growth factor cDNA from amphioxus. Proc Natl Acad Sci U S A 1990, 87:93199323.
48. Li C., Kim K. Neuropeptides. WormBook 2008, 25:1-36.
49. Kemmler W., Peterson J.D., Steiner D.F. Studies on the conversion of proinsulin to insulin: I. Conversion in vitro with trypsin and carboxypeptidase B. J Biol Chem 1971, 246:6786-6791.
50. Steiner D.F., Cho S., Oyer P.E., et al. Isolation and characterization of proinsulin C-peptide from bovine pancreas. J Biol Chem 1971, 246:1365-1374.
51. Kemmler W., Steiner D.F., Borg J. Studies on the conversion of proinsulin to insulin: 3. Studies in vitro with a crude secretion granule fraction isolated from islets of Langerhans. J Biol Chem 1973, 248:4544-4551.
52. Zühlke H., Steiner D.F., Lernmark N.A., et al. Carboxypeptidase B-like and trypsin-like activities in isolated rat pancreatic islets. CIBA Found Symp: Polypeptide hormones: molecular and cellular aspects 1976, 183-195. Excerpta Medica North-Holland, Amsterdam.
53. Fricker L.D., Evans C.J., Esch F.S., et al. Cloning and sequence analysis of cDNA for bovine carboxypeptidase E. Nature 1986, 323:461-464.
54. Dong W., Fricker L.D., Day R. Carboxypeptidase D is a potential candidate to carry out redundant processing functions of carboxypeptidase E based on comparative distribution studies in the rat central nervous system. Neuroscience 1999, 89:1301-1317.
55. Julius D., Brake A., Blair L., et al. Isolation of the putative structural gene for the lysine-arginine-cleavage endopeptidase required for processing of yeast prepro-α-factor. Cell 1984, 37:1075-1089.
56. Fuller R.S., Sterne R.E., Thorner J. Enzymes required for yeast prohormone processing. Annu Rev Physiol 1988, 50:345-362.
57. Mizuno K., Nakamura T., Ohshima T., et al. Yeast KEX2 gene encodes an endopeptidase homologous to subtilisin-like serine proteases. Biochem Biophys Res Commun 1988, 156:246-254.
58. Smeekens S.P., Steiner D.F. Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast diabasic processing protease Kex2. J Biol Chem 1990, 265:2997-3000.
59. Smeekens S.P., Avruch A.S., LaMendola J., et al. Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci U S A 1991, 88:340-344.
60. Seidah N.G., Chrétien M., Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie 1994, 76:197-209.
61. Zhou A., Webb G., Zhu X., et al. Proteolytic processing in the secretory pathway. J Biol Chem 1999, 274:20745-20748.
62. Seidah N.G., Prat A. The proprotein convertases are potential targets in the treatment of dyslipidemia. J Mol Med 2007, 85:685-696.
63. Davidson H.W., Rhodes C.J., Hutton J.C. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β cell via two distinct site-specific endopeptidases. Nature 1988, 333:93-96.
64. + is important for the proteolytic processing and intracellular transport of proinsulin in the pancreatic β-cell. Biochem J 1997, 323:445-450.
65. Smeekens S.P., Albiges-Rizo C., Carroll R., et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2 and PC3. Proc Natl Acad Sci U S A 1992, 89:8822-8826.
66. Rhodes C.J., Lincoln B., Shoelson S.E. Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase: implications of a favored route for prohormone processing. J Biol Chem 1992, 267:22719-22727.
67. Furuta M., Yano H., Zhou A., et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci U S A 1997, 94:6646-6651.
68. Zhu X., Zhou A., Dey A., et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci U S A 2002, 99:10293-10298.
69. Zhu X., Orci L., Carroll R., et al. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad Sci U S A 2002, 99:10299-10304.
70. Jackson R.S., Creemers J.W., Ohagi S., et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997, 16:303-306.
71. Zethelius B., Byberg L., Hales C.N., et al. Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men-report from 27 years of follow-up study. Diabetologia 2003, 46:20-26.
72. Rhodes C.J., Alarcon C. What β-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 1994, 43:511-517.
73. Sizonenko S., Irminger J.C., Buhler L., et al. Kinetics of proinsulin conversion in human islets. Diabetes 1993, 42:933-936.
74. Skelly R., Schuppin G., Ishihara H., et al. Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line. Diabetes 1996, 45:37-43.
75. Schuppin G.T., Rhodes C.J. Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing beta TC3 cells. Biochem J 1996, 313:259-268.
76. Kalidas K., Dow E., Saker P., et al. Prohormone convertase 1 in obesity, gestational diabetes mellitus, and NIDDM: no evidence for a major susceptibility role. Diabetes 1998, 47:287-289.
77. Yoshida H., Ohagi S., Sanke T., et al. Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes 1995, 44:389-493.
78. Utsunomiya N., Ohagi S., Sanke T., et al. Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity. Diabetologia 1998, 41:701-705.
79. Benzinou M., Creemers J.W., Choquet H., et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 2008, 40:943-945.
80. Wen J.H., Chen Y.Y., Song S.J., et al. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia 2009, 52:504-513.
81. Arvan P., Castle D. Protein sorting and secretion granule formation in regulated secretory cells. Trends Cell Biol 1992, 2:327-331.
82. Kuliawat R., Klumperman J., Ludwig T., et al. Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic beta-cells. J Cell Biol 1997, 137:595-608.
83. Arvan P., Kuliawat R., Prabakaran D., et al. Protein discharge from immature secretory granules displays both regulated and constitutive characteristics. J Biol Chem 1991, 266:1417114174.
84. Michael J., Carroll R., Swift H., et al. Studies on the molecular organization of rat insulin secretory granules. J Biol Chem 1987, 262:16531-16535.
85. Nicolson T.J., Bellomo E.A., Wijesekara N., et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009, 58:2070-2083.
86. Logothetopoulos J., Maneko M., Wrenshall G.A., et al. Zinc, granulation, and extractable insulin of islet cells following hyperglycemia or prolonged treatment with insulin. The structure and metabolism of the pancreatic islets, Wenner-Gren Center International Symposium Series 1964, Vol. 3:333-347. Pergamon Press, Oxford. S.E. Brolin, B. Hellman, H. Knutson (Eds.).
87. Peterson J.D., Steiner D.F. The amino acid sequence of the insulin from a primitive vertebrate, the Atlantic hagfish (Myxine glutinosa). J Biol Chem 1975, 250:5183-5191.
88. Blundell T.L., Dodson G.G., Hodgkin D.C., et al. Insulin: the structure in the crystal and its reflection in chemistry and biology. Adv Protein Chem 1972, 26:279-402.
89. Chan S.J., Seino S., Gruppuso P.A., et al. A mutation in the B chain coding region of the human insulin gene is associated with impaired proinsulin conversion in a family with hyperproinsulinemia. Proc Natl Acad Sci U S A 1987, 84:2194-2197.
90. Carroll R.J., Hammer R.E., Chan S.J., et al. A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acad Sci U S A 1988, 85:8943-8947.
91. Orci L. The insulin factory: a tour of the plant surroundings and a visit to the assembly line. Diabetolgia 1985, 28:528-546.
92. Louagie E., Taylor N.A., Flamez D., et al. Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate. Proc Natl Acad Sci U S A 2008, 105:112319-112324.
93. Cohen R.M., Given B.D., Licinio-Paixao J., et al. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism 1986, 35:1137-1146.
94. Halban P.A. Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetologia 1991, 34:767-778.
95. Polonsky K.S., Rubenstein A.H. Current approaches to measurement of insulin secretion. Diabetes Metab Rev 1986, 2:315-329.
96. Steiner D.F. The biosynthesis of insulin. Insulin-handbook of experimental pharmacology 1990, vol 92:67-92. Springer-Verlag, Berlin. P. Cuatrecasas, S. Jacobs (Eds.).
97. Steiner D.F., Clark J.L. The spontaneous reoxidation of reduced beef and rat proinsulins. Proc Natl Acad Sci U S A 1968, 60:622-629.
98. Guo Z.Y., Qiao Z.S., Feng Y.M. The in vitro oxidative folding of the insulin superfamily. Antioxid Redox Signal 2008, 10:127-139.
99. Kjeldsen T., Ludvigsen S., Diers I., et al. Engineering-enhanced protein secretory expression in yeast with application to insulin. J Biol Chem 2002, 277:18245-18248.
100. Lipkind G., Steiner D.F. Predicted structural alterations in proinsulin during its interactions with prohormone convertases. Biochemistry 1999, 38:890-896.
101. Liu M., Ramos-Cstaneda J., Arvan P. Role of the connecting peptide in insulin biosynthesis. J Biol Chem 2003, 278:14798-14805.
102. Okun M.M., Shields D. Translocation of preproinsulin across the endoplasmic reticulum membrane. J Biol Chem 1992, 267:11476-11482.
103. Powell S., Orci L., Craik C.S., et al. Efficient targeting to storage granules of human proinsulins with altered propeptide domain. J Cell Biol 1988, 106:1843-1851.
104. Wahren J., Johansson B.-L., Wallberg-Henriksson H. Does C-peptide have a physiological role?. Diabetologia 1994, 37:S99.
105. Wahren J., Ekberg K., Jörnvall H. C-peptide is a bioactive peptide. Diabetologia 2007, 50:503-509.
106. Ido Y., Vindigni A., Chang K., et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997, 277:563-566.
107. Galloway J.A., Hooper S.A., Spradlin C.T., et al. Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical experience. Diabetes Care 1992, 15:666-692.
108. Glauber H.S., Henry R.R., Wallace P., et al. The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med 1987, 316:443-449.
109. Madsen O.D., Frank B.H., Steiner D.F. Human proinsulin specific antigenic determinants identified by monoclonal antibodies. Diabetes 1984, 33:1012-1016.
110. Rhodes C.J., Halban P.A. Newly-synthesized proinsulin/insulin and stored insulin are released form pancreatic B-cells via a regulated, rather than a constitutive pathway. J Cell Biol 1987, 105:145-153.
111. Uchizono Y., Alarcon C., Wicksteed B.L., et al. The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead?. Diabetes Obes Metab 2007, 9:56-66.
112. Rhodes C.J. Processing of the insulin molecule. Diabetes mellitus: a fundamental and clinical text 2004, 27-50. Lippincott-Raven, Philadelphia. D. LeRoith, S.I. Taylor, J.M. Olefsky (Eds.).
113. Wicksteed B., Alarcón C., Briaud I., et al. Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet beta-cells, but not regulated via a positive feedback of secreted insulin. J Biol Chem 2003, 278:42080-42090.
114. Bollheimer L.C., Skelly R.H., Chester M., et al. Chronic exposure to free fatty acid reduces pancreatic β-cell insulin content by increasing basal insulin secretion that is not compensated for a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 1998, 101:1094-1101.
115. ++, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 1987, 67:1185-1248.
116. Alarcón C., Wicksteed B.L., Prentki M., et al. Elevation in pancreatic β-cell cytosolic succinyl-CoA is a candidate for specific metabolic stimulus coupling of proinsulin biosynthesis translation, but not insulin secretion. Diabetes 2002, 51:2496-2504.
117. Drucker D.J. The biology of incretin hormones. Cell Metab 2006, 3:153-165.
118. Alarcon C., Wicksteed B., Rhodes C.J. Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level. Diabetologia 2006, 49:2920-2929.
119. Herbert T.P., Alarcón C., Skelly R.H., et al. Regulation of prohormone conversion by coordinated control of processing endopeptidase biosynthesis with that of the prohormone substrate. Proteolytic and cellular mechanisms in prohormone and proprotein processing 1998, 105-120. R.G. Landes, Austin, TX. V.Y.H. Hook (Ed.).
120. Guest P.C., Bailyes E.M., Rutherford N.G., et al. Insulin secretory granule biogenesis: co-ordinate regulation of the biosynthesis of the majority of constituent proteins. Biochem J 1991, 274:73-78.
121. Alarcón C., Lincoln B., Rhodes C.J. The biosynthesis of the subtilisin-related proprotein convertase PC3, but not that of the PC2 convertase, is regulated by glucose in parallel to proinsulin biosynthesis in rat pancreatic islets. J Biol Chem 1993, 268:4276-4280.
122. Itoh N., Okamoto H. Translational control of proinsulin synthesis by glucose. Nature 1980, 283:100-102.
123. Welsh M., Scherberg N., Gilmore R., et al. Translational control of insulin biosynthesis. Evidence for regulation of elongation, initiation and signal-recognition-particle-mediated translational arrest by glucose. Biochem J 1986, 235:459-467.
124. Welsh M., Nielsen D.A., MacKrell A.J., et al. Control of insulin gene expression in pancreatic β-cells and in an insulin producing cell line, RIN-5F cells. 2. Regulation of insulin mRNA stability. J Biol Chem 1985, 260:13590-13594.
125. German M. Insulin gene regulation. Diabetes mellitus-a fundamental and clinical text 2004, 15-26. Lippincott Williams & Wilkins, Philadelphia. D. LeRoith, S.I. Taylor, J.M. Olefsky (Eds.).
126. Van Lommel L., Janssens K., Quintens R., et al. Probe-independent and direct quantification of insulin mRNA and growth hormone mRNA in enriched cell preparations. Diabetes 2006, 55:3214-3220.
127. Permutt M.A., Kipnis D.M. Insulin biosynthesis and secretion. Fed Proc 1975, 34:1549-1555.
128. Wicksteed B., Herbert T.P., Alarcón C., et al. Cooperation between 5'- and 3'-untranslated regions of preproinsulin mRNA control proinsulin biosynthesis. J Biol Chem 2001, 276:22553-22558.
129. Fred R.G., Tillmar L., Welsh N. The role of PTB in insulin mRNA stability control. Curr Diabetes Rev 2006, 2:363-366.
130. Wicksteed B.L., Uchizono Y., Alarcon C., et al. A cis-element in the 5'-untranslated region of the preproinsulin mRNA (ppIGE) is required for glucose regulation of proinsulin translation. Cell Metab 2007, 5:221-227.
131. German M.S., Moss L.G., Rutter W.J. Regulation of gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem 1990, 265:22063-22066.
132. Swenne I. The role of glucose in the in vitro regulation of cell cycle kinetics and proliferation of fetal pancreatic β-cells. Diabetes 1982, 31:754-760.
133. Lingohr M.K., Buettner R., Rhodes C.J. Pancreatic beta-cell growth and survival-a role in obesity-linked type 2 diabetes?. Trends Mol Med 2002, 8:375-384.
134. Orci L., Ravazzola M., Amherdt M., et al. Insulin, not C-peptide (proinsulin), is present in crinophagic bodies of the pancreatic B-cell. J Cell Biol 1984, 98:222-228.
135. Schnell A.H., Swenne I., Borg L.A. Lysosomes and pancreatic islet function. A quantitative estimation of crinophagy in the mouse pancreatic B-cell. Cell Tissue Res 1988, 252:9-15.
136. Marsh B.J., Soden C., Alarcón C., et al. Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine β-cells. Mol Endocrinol 2007, 21:2255-2269.
137. Halban P.A., Wollheim C.B. Intracellular degradation of insulin stores by rat pancreatic islets in vitro. An alternative pathway for homeostasis of pancreatic insulin content. J Biol Chem 1980, 255:6003-6006.
138. Skoglund G., Ahren B., Lundquist I. Biochemical determination of islet lysosomal enzyme activities following crinophagy-stimulating treatment with diazoxide in mice. Diabetes Res 1987, 6:81-84.
139. Ebato C., Uchida T., Arakawa M., et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 2008, 8:325-332.
140. Grasso D., Sacchetti M.L., Bruno L., et al. Autophagy and VMP1 expression are early cellular events in experimental diabetes. Pancreatology 2008, 9:81-88.
141. Ashcroft F.M., Rorsman P. Electrophysiology of the pancreatic beta cell. Prog Biophys Mol Biol 1989, 54:87-143.
142. Matschinsky F.M., Magnuson M.A., Zelent D., et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 2006, 55:1-12.
143. Conget I., Zhang T.M., Eizirik D.L., et al. SAM prevents impairment of glucose-stimulated insulin secretion caused by hexose deprivation or starvation. Am J Physiol 1995, 268:E580-E587.
144. De Leon D.D., Stanley C.A. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007, 3:57-68.
145. Doliba N.M., Qin W., Najafi H., et al. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab 2012, 302:E87-E102.
146. Steele A.M., Shields B.M., Wensley K.J., et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 2014, 311:279-286.
147. Fridlyand L.E., Jacobson D.A., Philipson L.H. Ion channels and regulation of insulin secretion in human beta-cells: a computational systems analysis. Islets 2013, 5:1-15.
148. Beauvois M.C., Merezak C., Jonas J.C., et al. Glucose-induced mixed [Ca2+]c oscillations in mouse beta-cells are controlled by the membrane potential and the SERCA3 Ca2+-ATPase of the endoplasmic reticulum. Am J Physiol Cell Physiol 2006, 290:C1503-C1511.
149. Fridlyand L.E., Tamarina N., Philipson L.H. Bursting and calcium oscillations in pancreatic beta-cells: specific pacemakers for specific mechanisms. Am J Physiol Endocrinol Metab 2010, 299:E517-E532.
150. Gloyn A.L., Pearson E.R., Antcliff J.F., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838-1849.
151. Greeley S.A., Naylor R.N., Philipson L.H., et al. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep 2011, 11:519-532.
152. Aguilar-Bryan L., Bryan J. Neonatal diabetes mellitus. Endocr Rev 2008, 29:265-291.
153. Misler S., Barnett D.W., Gillis K.D., et al. Electrophysiology of stimulus-secretion coupling in human B-cells. Diabetes 1992, 41:1221-1228.
154. Rorsman P., Braun M., Zhang Q. Regulation of calcium in pancreatic alpha- and beta-cells in health and disease. Cell Calcium 2012, 51:300-308.
155. Wiederkehr A., Wollheim C.B. Mitochondrial signals drive insulin secretion in the pancreatic beta-cell. Mol Cell Endocrinol 2012, 353:128-137.
156. Henquin J.C. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 2009, 52:739-751.
157. Mourad N.I., Nenquin M., Henquin J.C. Metabolic amplifying pathway increases both phases of insulin secretion independently of beta-cell actin microfilaments. Am J Physiol Cell Physiol 2010, 299:C389-C398.
158. Seino S., Shibasaki T., Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 2011, 121:2118-2125.
159. Chimienti F., Devergnas S., Favier A., et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004, 53:2330-2337.
160. Wenzlau J.M., Juhl K., Yu L., et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007, 104:17040-17045.
161. Sladek R., Rocheleau G., Rung J., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
162. Nicolson T.J., Bellomo E.A., Wijesekara N., et al. Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes 2009, 58:2070-2083.
163. Nesher R., Anteby E., Yedovizky M., et al. Beta-cell protein kinases and the dynamics of the insulin response to glucose. Diabetes 2002, 51(Suppl 1):S68-S73.
164. Drucker D.J. The biology of incretin hormones. Cell Metab 2006, 3:153-165.
165. Meloni A.R., DeYoung M.B., Lowe C., et al. GLP-1 receptor activated insulin secretion from pancreatic beta-cells: mechanism and glucose dependence. Diabetes Obes Metab 2013, 15:15-27.
166. Wek R.C., Anthony T.G. EXtENDINg beta cell survival by UPRegulating ATF4 translation. Cell Metab 2006, 4:333-334.
167. Holz G.G., Chepurny O.G., Leech C.A. Epac2A makes a new impact in beta-cell biology. Diabetes 2013, 62:2665-2666.
168. Philipson L.H. Beta-agonists and metabolism. J Allergy Clin Immunol 2002, 110(6 Suppl):S313-S317.
169. Fagerholm V., Haaparanta M., Scheinin M. Alpha2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin Pharmacol Toxicol 2011, 108:365-370.
170. Straub S.G., Sharp G.W. Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins. Am J Physiol Cell Physiol 2012, 302:C1687-C1698.
171. Draznin B., Steinberg J.P., Goodman M., et al. Control of secretion, vesicle margination, and lysis by glucose, IBMX, and glyburide. Am J Physiol 1985, 248:E375-E380.
172. Dov A., Abramovitch E., Warwar N., et al. Diminished phosphodiesterase-8B potentiates biphasic insulin response to glucose. Endocrinology 2008, 149:741-748.
173. Fridlyand L.E., Harbeck M.C., Roe M.W., et al. Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach. Am J Physiol Cell Physiol 2007, 293:C1924-C1933.
174. Drucker D.J., Sherman S.I., Gorelick F.S., et al. Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care 2010, 33:428-433.
175. Gilon P., Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 2001, 22:565-604.
176. Ruiz de Azua I., Gautam D., Jain S., et al. Critical metabolic roles of beta-cell M3 muscarinic acetylcholine receptors. Life Sci 2012, 91:986-991.
177. Mancini A.D., Poitout V. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?. Trends Endocrinol Metab 2013, 24:398-407.
178. Stoy J., Edghill E.L., Flanagan S.E., et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A 2007, 104:15040-15044.
179. Murphy R., Ellard S., Hattersley A.T. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008, 4:200-213.
180. Rosengren A.H., Braun M., Mahdi T., et al. Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 2012, 61:1726-1733.
181. Steiner D.F., Chan S.J., Welsh J.M., et al. Structure and evolution of the insulin gene. Annu Rev Genet 1985, 19:463-484.
182. Pugliese A., Zeller M., Fernandez A., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997, 15:293-297.
183. Bell G.I., Selby M.J., Rutter W.J. The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature 1982, 295:31-35.
184. Steiner D.F., Tager H.S., Chan S.J., et al. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 1990, 13:600-609.
185. Rafiq M., Flanagan S.E., Patch A.M., et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008, 31:204-209.
186. Edghill E., Flanagan S., Patch A.M., et al. Insulin mutation screening in 1044 patients with diabetes mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008, 57:1034-1042.
187. Molven A., Ringdal M., Nordbø A.M., et al. Mutations in the insulin gene can cause MODY and autoantibody-negative type I diabetes. Diabetes 2008, 57:1131-1135.
188. Polak M., Dechaume A., Cave H., et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy. Diabetes 2008, 57:1115-1119.
189. Støy J., Steiner D.F., Park S.Y., et al. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 2010, 11:204-215.
190. Hua Q.X., Liu M., Hu S.Q., et al. A conserved histidine in insulin is required for the foldability of human proinsulin: structure and function of an ALAB5 analog. J Biol Chem 2006, 281:24889-24899.
191. Rajan S., Eames S.C., Park S.Y., et al. In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab 2010, 289:E403-E410.
192. Park S.Y., Ye H., Steiner D.F., et al. Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted. Biochem Biophys Res Commun 2010, 391:1449-1454.
193. Bonfanti R., Colombo C., Nocerino V., et al. Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 2009, 32:123-125.
194. Qiao Z.S., Min C.Y., Hua Q.X., et al. In vitro refolding of human proinsulin. Kinetic intermediates, putative disulfide-forming pathway, folding initiation site and potential role of C-peptide in folding process. J Biol Chem 2003, 278:17800-17809.
195. Nakagawa S.H., Hua Q.X., Hu S.Q., et al. Chiral mutagenesis of insulin. Contribution of the B20-B23 beta-turn to activity and stability. J Biol Chem 2006, 281:22386-22396.
196. Wang J., Takeuchi T., Tanaka S., et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the MODY mouse. J Clin Invest 1999, 103:27-37.
197. C95S mutant mice. Diabetes 2007, 56:1268-1276.
198. Shimizu Y., Hendershot L.M. Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid Redox Signal 2009, 11:2317-2331.
199. Sevier C.S., Kaiser C.A. Ero1 and redox homeostasis in the endoplasmic reticulum. Biochim Biophys Acta 2008, 1783:549-556.
200. Back S.H., Scheuner D., Han J., et al. Translation attenuation through elF2a phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. Cell Metab 2009, 10:13-26.
201. Zhu Y.L., Abdo A., Gesmonde J.F., et al. Aggregation and lack of secretion of most newly synthesized proinsulin in non-β-cell lines. Endocrinology 2004, 145:3840-3849.
202. Zuber C., Fan J.Y., Guhl B., et al. Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 2004, 18:917-999.
203. Hutton J.C. The insulin secretory granule. Diabetologia 1989, 32:271-281.
204. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003, 348:1134-1149.
205. Hutton J.C., Nielsen E., Kastern W. The molecular cloning of the chromogranin A-like precursor of β-granin and pancreastatin from the endocrine pancreas. FEBS Lett 1988, 236:269-274.
206. Schmidt W.E., Siegel E.G., Kratzin H., et al. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci U S A 1988, 85:8231-8235.
207. Tatemoto K., Efendic S., Mutt V., et al. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478.
208. Hendy G.N., Li T., Girard M., et al. Targeted ablation of the chromogranin a (CHGA) gene: normal neuroendocrine dense-core secretory granules and increased expression of other granins. Mol Endocrinol 2006, 8:1935-1947.
209. Westermark P., Wernstedt C., Wilander E., et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986, 140:827-831.
210. Cooper G.J., Willis A.C., Clark A., et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A 1987, 84:8628-8632.
211. Opie E. The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islands of Langerhans. J Exp Med 1901, 5:527-540.
212. Nishi M., Sanke T., Seino S., et al. Human islet amyloid polypeptide gene: sequence, chromosomal localization and evolutionary history. Mol Endocrinol 1989, 3:1775-1781.
213. Mosselman S., Höppener J.W., Lips C.J., Jansz H.S. The complete islet amyloid polypeptide precursor is encoded by two exons. FEBS Lett 1989, 247:154-158.
214. Prigge S.T., Eipper B.A., Mains R.E., et al. New insights into copper monoxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 2000, 57:1236-1259.
215. Iki K., Pour P.M. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases. J Histochem Cytochem 2007, 55:111-118.
216. Nagamatsu S., Nishi M., Steiner D.F. Biosynthesis of islet amyloid polypeptide. Elevated expression in mouse beta TC3 cells. J Biol Chem 1991, 266:13737-13741.
217. Wang J., Xu J., Finnerty J., et al. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 2001, 50:534-539.
218. Marzban L., Trigo-Gonzalez G., Zhu X., et al. Role of beta-cell prohormone convertase (PC) 1/3 in processing of pro-islet amyloid polypeptide. Diabetes 2004, 53:141-148.
219. Marzban L., Park K., Verchere C.B. Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 2003, 38:347-351.
220. Marzban L., Rhodes C.J., Steiner D.F., et al. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 2006, 55:2192-2201.
221. Mulder H., Ahren B., Stridsberg M., et al. Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment. Diabetologia 1995, 38:395-402.
222. Ferrier G.J., Pierson A.M., Jones P.M., et al. Expression of the rat amylin (IAPP/DAP) gene. J Mol Endocrinol 1989, 3:R1-R4.
223. Nakazato M., Asai J., Kangawa K., et al. Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentration. Biochem Biophys Res Commun 1989, 164:394-399.
224. Asai J., Nakazato M., Kangawa K., et al. Regional distribution and molecular forms of rat islet amyloid polypeptide. Biochem Biophys Res Commun 1990, 169:788-795.
225. Kanatsuka A., Makino H., Ohsawa H., et al. Secretion of islet amyloid polypeptide in response to glucose. FEBS Lett 1989, 259:199-201.
226. Cooper G.J.S. Amylin and related proteins: physiology and pathology. Handbook of physiology, The Endocrine System 2001, Vol. II:303-396. Oxford University Press. L.S. Jefferson, A.D. Cunningham (Eds.).
227. Sowa R., Sanke T., Hirayama J., et al. Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 1990, 33:118-120.
228. Scherbaum W.A. The role of amylin in the physiology of glycemic control. Exp Clin Endocrinol Diabetes 1998, 106:97-102.
229. Gebre-Medhin S., Mulder H., Pekny M., et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 1998, 250:271-277.
230. Ahrén B., Oosterwijk C., Lips C.J., Höppener J.W. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Diabetologia 1998, 41:1374-1380.
231. Datta H.K., Saidi M., Wimalawansa S.J., et al. In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem Biophys Res Commun 1989, 162:876-881.
232. MacIntyre I., Amylinamide bone conservation, and pancreatic beta cells. Lancet 1989, 2:1026-1027.
233. Christopoulos G., Perry K.J., Morfis M., et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999, 56:235-242.
234. Morfis M., Tilakaratne N., Furness S.G., et al. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. Endocrinology 2008, 149:5423-5431.
235. Schmitz O., Brock B., Rungby J. Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 2004, 53:S233-S238.
236. O'Brien T.D., Butler P.C., Westermark P., et al. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol 1993, 30:317-332.
237. Glenner G.G., Eanes E.D., Wiley C.A. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem Biophys Res Commun 1988, 155:608-614.
238. Hallman U., Wernstedt C., Westermark P., et al. Amino acid sequence from degu islet amyloid-derived insulin shows unique sequence characteristics. Biochem Biophys Res Commun 1980, 169:571-577.
239. Nishi M., Steiner D.F. Cloning of complementary DNAs encoding islet amyloid polypeptide, insulin, and glucagon precursors from a New World rodent, the degu, Octodon degus. Mol Endocrinol 1990, 4:1192-1198.
240. Lukinius A., Wilander E., Westermark G.T., et al. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989, 32:240-244.
241. Clark A., Wells C.A., Buley I.D., et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas. Diabetes Res 1988, 9:151-159.
242. Clark A., Edwards C.A., Ostle L.R., et al. Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human β-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 1989, 257:179-185.
243. Westermark G., Westermark P., Eizirik D.L., et al. Differences in amyloid deposition in islets of transgenic mice expressing human islet amyloid polypeptide versus human islets implanted into nude mice. Metabolism 1999, 48:448-454.
244. Kahn S.E., Andrikopoulos S., Verchere C.B. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 1999, 48:241-253.
245. Nishi M., Bell G.I., Steiner D.F. Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990, 33:628-630.
246. Andersson A., Bohman S., Borg L.A., et al. Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure. Exp Diabetes Res 2008, 2008:562985.
247. Porat Y., Mazor Y., Efrat S., et al. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions. Biochemistry 2004, 43:14454-14462.
248. Tatarek-Nossol M., Yan L.-M., Schmauder A., et al. Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid-core-containing hexapeptide. Chem and Biol 2005, 12:797-809.
249. Steiner D.F., Bell G.I., Rubenstein A.H., et al. Chemistry and biosynthesis of the islet hormones: insulin, islet amyloid polypeptide (amylin), glucagon, somatostatin, and pancreatic polypeptide. Endocrinology 2006, 925-960. Saunders, Philadelphia. 5th ed. L. De Groot, J.L. Jameson (Eds.).
250. Tanaka S., Kurabuchi S., Mochida H., et al. Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets. Arch Histol Cytol 1996, 59:261-271.
251. Furuta M., Zhou A., Webb G., et al. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem 2001, 276:27197-27202.
252. Gelling R.W., Du X.Q., Dichmann D.S. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 2003, 100:1438-1443.
253. Webb G.C., Akbar M.S., Zhao C., et al. Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in PC2 knockout mice. Diabetes 2002, 51:398-405.
254. Wilson M.E., Kalamaras J.A., German M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev 2002, 115:171-176.
255. Nie Y., Nakashima M., Brubaker P.L., et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest 2000, 105:955-965.
256. Csaba Z., Dournaud P. Cellular biology of somatostatin receptors. Neuropeptides 2001, 35:1-23.
257. Egel-Mitani M., Flygenring H.P., Hansen M.T. A novel aspartyl protease allowing KEX2-independent MF alpha propheromone processing in yeast. Yeast 1990, 6:127-137.
258. Zhu X., Cao Y., Voogd K., et al. On the processing of proghrelin to ghrelin. J Biol Chem 2006, 281:38867-38870.
259. Yang J., Brown M.S., Liang G., et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
260. Andralojc K.M., Mercalli A., Nowak K.W., et al. Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 2009, 52:486-493.
261. Webb G.B., Akbar M.S., Zhao C., et al. Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc Natl Acad Sci U S A 2000, 97:5773-5778.
262. 3. Endocrinology 1999, 140:3633-3642.